Page last updated: 2024-09-03

glabridin and Angiogenesis, Pathologic

glabridin has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Li, Y; Li, Z; Liu, Y; Mu, J; Ning, S; Shen, Z; Zhu, D1
Hsu, YL; Huang, MS; Hung, JY; Kuo, PL; Lien, CT; Tsai, YC; Tsai, YM; Wu, LY; Yang, CJ1

Other Studies

2 other study(ies) available for glabridin and Angiogenesis, Pathologic

ArticleYear
The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
    BMC cancer, 2017, 05-02, Volume: 17, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; MicroRNAs; Neovascularization, Pathologic; Phenols; Signal Transduction; Wnt Signaling Pathway

2017
Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway.
    Integrative cancer therapies, 2011, Volume: 10, Issue:4

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin beta3; Isoflavones; Lung Neoplasms; Mice; Mice, Nude; Myosin Light Chains; Neovascularization, Pathologic; Phenols; Phosphorylation; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases

2011